Thermo Fisher Scientific to Acquire CorEvitas from Audax Private Equity
Thermo Fisher Scientific Inc. announced that it entered into a definitive agreement to acquire CorEvitas, LLC from Audax Private Equity, for $912.5 million. The transaction is expected to be completed by the end of 2023. CorEvitas, based in Waltham, Massachusetts, with operations focused in the United States, provides regulatory-grade, real-world evidence solutions to pharmaceutical and biotechnology companies with objective data and clinical insights to improve patient care and clinical outcomes. CorEvitas manages 12 registries, including nine autoimmune and inflammatory syndicated registries. Its multi-therapeutic data intelligence platform builds and scales multiple clinical registries... Read More »
Elevate ENT Enters Louisiana with Acquisition of Louisiana Ear, Nose, Throat and Sinus
Elevate ENT Partners, backed by Audax Private Equity, announced on May 30 that it acquired Louisiana Ear, Nose, Throat and Sinus (LENTS). The transaction makes LENTS the first Elevate ENT practice in the state of Louisiana. Financial terms of the deal were not disclosed. LENTS provides patients in the Baton Rouge and surrounding communities with ear, nose and throat (ENT) and sinus treatment. According to the company’s website, there are 14 physicians on staff. With more than 75 otolaryngology centers and 120 physicians, Elevate ENT Partners invests in private ENT and allergy practices across the United States. It provides scalable infrastructure to help practices reach the next... Read More »
Gastro Health Sold to OMERS Private Equity
One of the largest gastrointestinal physician groups has been sold to a Canadian private equity firm. OMERS Private Equity, based in Toronto, has purchased Gastro Health, LLC from Audax Private Equity. No terms were disclosed. Gastro Health is a medical group specializing in the treatment of gastrointestinal disorders, nutrition and digestive health. The group has more than 250 physicians with locations in Alabama, Florida, Maryland, Ohio, Virginia and Washington. Audax Private Equity has sponsored Gastro Health since it acquired them in 2016, and the partnership has produced nearly 20 transactions, including two this year. In March, the physician group purchased Digestive Disease... Read More »
Home Health & Hospice Sector Deals Dipped in Q3:19
Deal volume in the home health and hospice sector dipped slightly in the third quarter of 2019, down 23% with 20 publicly announced transactions, compared with 26 acquisitions in the second quarter, according to data from HealthCareMandA.com. Compared with the third quarter of 2018, home health and hospice M&A activity decreased by 20%, when 25 acquisitions were announced. Six of the transactions disclosed prices in the third quarter of 2019, for a combined total of nearly $1.2 billion. In the same quarter of 2018, the total dollar value based on disclosed prices was just $7.2 million. Of the 20 transactions announced in the third quarter, 35% were announced by private equity firms or... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
